- Home
- STCN vs IOBT Comparison
STCN vs IOBT Comparison
Compare STCN & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STCN
- IOBT
- Stock Information
- Founded
- STCN 1986
- IOBT 2014
- Country
- STCN United States
- IOBT Denmark
- Employees
- STCN N/A
- IOBT N/A
- Industry
- STCN Advertising
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- STCN Consumer Discretionary
- IOBT Health Care
- Exchange
- STCN Nasdaq
- IOBT Nasdaq
- Market Cap
- STCN 75.0M
- IOBT 77.7M
- IPO Year
- STCN 1994
- IOBT 2021
- Fundamental
- Price
- STCN $11.54
- IOBT $0.84
- Analyst Decision
- STCN
- IOBT Strong Buy
- Analyst Count
- STCN 0
- IOBT 3
- Target Price
- STCN N/A
- IOBT $8.67
- AVG Volume (30 Days)
- STCN 7.9K
- IOBT 301.4K
- Earning Date
- STCN 11-06-2024
- IOBT 08-13-2024
- Dividend Yield
- STCN N/A
- IOBT N/A
- EPS Growth
- STCN 203.29
- IOBT N/A
- EPS
- STCN 3.17
- IOBT N/A
- Revenue
- STCN $169,044,000.00
- IOBT N/A
- Revenue This Year
- STCN N/A
- IOBT N/A
- Revenue Next Year
- STCN N/A
- IOBT N/A
- P/E Ratio
- STCN $3.64
- IOBT N/A
- Revenue Growth
- STCN N/A
- IOBT N/A
- 52 Week Low
- STCN $7.36
- IOBT $0.80
- 52 Week High
- STCN $13.00
- IOBT $2.10
- Technical
- Relative Strength Index (RSI)
- STCN 47.58
- IOBT 27.78
- Support Level
- STCN $10.16
- IOBT $1.53
- Resistance Level
- STCN $11.98
- IOBT $1.62
- Average True Range (ATR)
- STCN 0.49
- IOBT 0.11
- MACD
- STCN -0.05
- IOBT -0.09
- Stochastic Oscillator
- STCN 75.82
- IOBT 5.06
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.